The Rho kinase (ROCK) inhibitor Y-27632 reduces the β2-adrenoceptor density but enhance cAMP formation in primary equine bronchial epithelial cells.

The research article investigates how the Rho kinase (ROCK) inhibitor Y-27632 impacts the density of β-adrenoceptors and the formation of β-agonist-stimulated intracellular second messenger cAMP in primary equine bronchial epithelial cells, and its implications for asthma therapy.

Study Method and Findings

• The study examined the effects of Rho-kinase (ROCK) inhibitor Y-27632 on β-adrenoceptor density and β-agonist-stimulated intracellular cAMP formation in primary equine bronchial epithelial cells (EBEC).
• The researchers observed that Y-27632 significantly reduced the number of β-adrenoceptors but did not affect the receptor affinity to the radioligand [I]-iodocyanopindolol, a type of tracing compound used in research.
• Conversely, Y-27632 boosted the production of cAMP (a type of intracellular second messenger) in response to β-agonist stimulation. The compound increased the maximum cAMP responses to isoproterenol, epinephrine, and norepinephrine, but did not influence the β-agonist concentration-effect curves.

Suggestions of β-Subtype Influence

• The β-selective antagonist ICI 118.551 and the ββ-antagonist propranolol, but not the β-selective antagonist CGP 20712A, was able to reverse the isoproterenol-induced cAMP formation equally in Y-27632-treated and control EBEC. This suggested that the observed impact was mainly related to the β-subtype.

Interactions Between β-adrenoceptor and Rho-kinase

• The study’s results led to the understanding that Y-27632 differentially regulates the receptor density and function. This implies that the interaction between β-adrenoceptor and Rho-kinase pathways reduces receptor expression while enhancing receptor downstream cAMP formation.
• This differential regulation of the receptor density and function by Y-27632 raises questions regarding the drug’s beneficial effects in treating asthma and should be further reconsidered.